| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 559,474 | 628,110 | 648,325 | 721,451 |
| Prepaid expenses and other current assets | 18,744 | 19,181 | 23,231 | 22,058 |
| Research and development incentives receivable | 40,917 | 35,594 | 67,263 | 60,753 |
| Total current assets | 619,135 | 682,885 | 738,819 | 804,262 |
| Property and equipment, net | 5,734 | 6,021 | 6,861 | 8,307 |
| Operating lease right-of-use assets | 14,535 | 15,886 | 4,562 | 5,806 |
| Other assets | 12,992 | 12,805 | 13,712 | 13,809 |
| Total assets | 652,396 | 717,597 | 763,954 | 832,184 |
| Accounts payable | 5,970 | 9,669 | 12,653 | 18,263 |
| Accrued expenses and other current liabilities | 40,124 | 44,354 | 44,368 | 44,538 |
| Deferred revenue, current portion | 2,795 | 2,961 | 12,261 | 14,621 |
| Total current liabilities | 48,889 | 56,984 | 69,282 | 77,422 |
| Operating lease liabilities, net of current portion | 13,874 | 14,096 | 981 | 1,765 |
| Deferred revenue, net of current portion | 34,340 | 35,508 | 74,119 | 82,943 |
| Other long-term liabilities | 973 | 1,032 | 1,093 | 1,139 |
| Total liabilities | 98,076 | 107,620 | 145,475 | 163,269 |
| Ordinary shares, including non-voting ordinary shares, 0.01 nominal value 163,361,109 and 159,685,229 shares authorized on march 31, 2026 and december 31, 2025, respectively 69,707,026 and 69,367,896 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 899 | 894 | 894 | 893 |
| Additional paid-in capital | 1,519,276 | 1,512,339 | 1,500,653 | 1,491,882 |
| Accumulated other comprehensive loss | -5,279 | -3,505 | -3,471 | -3,363 |
| Accumulated deficit | -960,576 | -899,751 | -879,597 | -820,497 |
| Total shareholders' equity | 554,320 | 609,977 | 618,479 | 668,915 |
| Total liabilities and shareholders' equity | 652,396 | 717,597 | 763,954 | 832,184 |
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)